HighTower Advisors
SPPI

HighTower Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

HighTower Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,777
Closed -$38K – 3452
2021
Q1 		$38K Buy
+11,777
New +$42.2K ﹤0.01% 2861

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

HighTower Advisors's SPPI Position: Q2 2021 in Review

HighTower Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2021, closing a stake of 11,777 shares — an estimated $38K sold.

HighTower Advisors first reported a position in SPPI in Q1 2021 and held it in 1 quarter. The position peaked at $38K in Q1 2021. 156 funds tracked by Wall St. Rank hold SPPI as of Q2 2021.

  • HighTower Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
  • HighTower Advisors sold 11,777 Spectrum Pharmaceuticals Inc shares in Q2 2021, an estimated $38K.
  • HighTower Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q1 2021 and held it in 1 quarter.
  • HighTower Advisors's Spectrum Pharmaceuticals Inc position peaked at $38K in Q1 2021.
  • 156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2021.

Based on HighTower Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.